Through the miracle of modern-day ultrasound, we are able to see – in three dimensions and in real time – the functioning of arteries, veins and the many sophisticated structures of the heart. While most think of ultrasound technology as it relates to grinning parents getting a first glance of their baby in the womb, cardiovascular care is being revolutionised by advances in ultrasound…
Crowds of hospital delegates flocking in to Xiamen on the first day of CMEF had already suggested that the event will be welcoming more than the roughly 60,000 delegates expected to participate
Over the past decade, laboratory medicine developed rapid, accurate tests that help in diagnoses, prognoses, treatments – and the overall theragnostics; but is it economical? This November, at the Journées Internationales de Biologie (JIB) meeting in Paris, that question will shape the medical economics session Medical biology: a key factor in the healthcare effectiveness, organised by the in…
Already popular in private healthcare, increasing global acceptance of refurbished equipment encourages uptake in the public sector.
This year a further one in six of England’s hospitals started to offer patients the choice of ‘self-funding’ for treatments and services that are subject to restrictions or long NHS waiting times. These include IVF treatment, cataract surgery, varicose veins, carpal tunnel syndrome therapy and hernia repair.
United Kingdom – The Royal College of General Practitioners, Royal College of Radiologists and the Society and College of Radiographers have worked together on recommendations that outline improvements for patients by ensuring that timely and appropriate medical imaging services are provided to them and their referring doctors.
The current financial crisis is having a major impact on European economies, especially that of Spain. Past evidence suggests that adverse macro- economic conditions exacerbate mental illness, but evidence from the current crisis is limited.
Samsung BioLogics today announced that Samsung BioLogics and F. Hoffmann-La Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction.
In intensive care units (ICUs) little can be automated to relieve staff pressures – with the exception of point of care testing (POCT)
Nat Whitney, President of Whitney Research, sums up the ups and downs of the international IVD market and reports on a fitting finale for 17 years of dedicated service
Eucomed, the European medical technology industry association, expresses disappointment and strong concern at the outcome of a vote in the European Parliament’s Committee for Environment, Public Health and Food Safety (ENVI).
There is a global shortage of doctors that is getting worse every year. With the demographic shift in many countries from a predominantly young to an increasing aging population, a steep increase in chronic disease is occurring.
Snibe, the Shenzhen New Industries Biomedical Engineering Company Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and in vitro reagents. Founded 18 years ago and a growing force in the Chinese market, the firm is based in Shenzhen, China’s fourth largest city, situated in Guangdong Province.
The results of a survey amongst medical device companies in Europe about the financial impact of the upcoming changes in the European medical device regulation show a significant increase in costs for bringing new devices to patients.
Experts from DEGUM, the German Society for Ultrasound in Medicine, are convinced that the use of ultrasound in preclinical and clinical emergency medicine can be further optimised, according to interim study results that indicate, in cases of unclear symptoms, the diagnosis and therefore decision for appropriate A&E treatment can be accelerated by using ultrasound.
The new Hospital Engineering Lab in Duisburg, Germany, which was officially opened in July by Barbara Steffens, Health Minister for the German federal state, is a project of four Fraunhofer Institutes.
About 500,000 people in France people suffer heart failure (HF). In Europe the figure is six million and the same in the USA.
A new procedure may help people with persistent hypertension. By burning or ablating the nerves in the renal arteries, blood pressure levels can be reduced significantly.
Each year the case grows stronger for transcatheter aortic valve replacement (TAVI). And it is only six years since the procedure was introduced in Europe.
Nothing new has been invented in heart failure in the last 15 years, according to Christian Homsy, CEO of Belgian-based Cardio3 Biosciences. This explains the excitement surrounding an emerging treatment among cardiologists, patients and investors.
The Catharina Hospital (Eindhoven, the Netherlands) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced the results of a clinical study involving the treatment of 136 patients with complex heart rhythm disorders such as atrial fibrillation (AF).
Which technological advancements can we expect to see in the field of medical technology? How well can diagnosis and therapy be customized for each patient?
A record 1,700 participants from 84 countries confirmed the dimension and international importance of the European Association of Endoscopic Surgery Congress held recently in Vienna, where Hans-Christian Pruszsinsky caught up with Congress President Professor Selman Uranüs, Head of the Section for Surgical Research, Medical University of Graz, for our interview.
Managed Equipment Service (MES) contracts have the potential to transform equipment-supply financing for healthcare, according to Siemens Financial Services’ Ulrich Stark, Head of Debt Origination for Healthcare in EMEA, and Anthony Casciano, CEO of Project, Structured & Leveraged Finance Healthcare
Labs need to optimise their costs as well as accommodate increasing volumes – and new tests are continuously demanded.